Seattle, WA, United States of America

Gary L Schieven

USPTO Granted Patents = 10 

Average Co-Inventor Count = 1.8

ph-index = 6

Forward Citations = 101(Granted Patents)


Location History:

  • Seattle, WA (US) (1996 - 1999)
  • Lawrenceville, NJ (US) (2001 - 2024)

Company Filing History:


Years Active: 1996-2024

Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Gary L. Schieven

Introduction

Gary L. Schieven is a prominent inventor based in Seattle, WA, known for his significant contributions to the field of medical research and pharmaceutical development. With a total of 10 patents to his name, Schieven has made strides in the treatment of serious health conditions, particularly in oncology.

Latest Patents

Among his latest patents, Schieven has developed methods for treating bladder cancer and solid tumors. These methods involve administering a compound of a specific formula to patients, showcasing his innovative approach to tackling complex medical challenges. The pharmaceutical compositions related to this compound further highlight his commitment to advancing cancer treatment.

Career Highlights

Throughout his career, Gary L. Schieven has worked with notable companies such as Bristol-Myers Squibb Company and Venenum Biodesign, LLC. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Schieven has collaborated with esteemed colleagues, including Joel C. Barrish and Jagabandhu Das. These partnerships have played a crucial role in enhancing his research and expanding the impact of his inventions.

Conclusion

Gary L. Schieven's work exemplifies the spirit of innovation in the medical field. His patents and collaborations reflect a dedication to improving patient outcomes and advancing cancer treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…